Antony P. Martin

3.0k total citations
67 papers, 1.1k citations indexed

About

Antony P. Martin is a scholar working on Hematology, Economics and Econometrics and Genetics. According to data from OpenAlex, Antony P. Martin has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 16 papers in Economics and Econometrics and 10 papers in Genetics. Recurrent topics in Antony P. Martin's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Hemoglobinopathies and Related Disorders (10 papers) and Hemophilia Treatment and Research (9 papers). Antony P. Martin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Hemoglobinopathies and Related Disorders (10 papers) and Hemophilia Treatment and Research (9 papers). Antony P. Martin collaborates with scholars based in United Kingdom, United States and Australia. Antony P. Martin's co-authors include Jamie R. Flynn, William M. Palmer, John W. Patrick, William D. Palmer, Ameha Seyoum Woldu, Susan Hua, Doug W. Smith, Christopher P. L. Grof, Robert T. Furbank and Brian Godman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Antony P. Martin

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antony P. Martin United Kingdom 16 328 233 152 127 99 67 1.1k
Sharmistha Ghosh United States 18 87 0.3× 356 1.5× 102 0.7× 211 1.7× 93 0.9× 29 1.2k
Nengming Lin China 21 108 0.3× 432 1.9× 101 0.7× 284 2.2× 35 0.4× 81 1.3k
Amy J. Clippinger United States 22 92 0.3× 490 2.1× 220 1.4× 97 0.8× 8 0.1× 41 1.7k
Hyun‐Jung Choi South Korea 17 154 0.5× 325 1.4× 234 1.5× 102 0.8× 59 0.6× 108 1.2k
Robert Dawe United Kingdom 35 73 0.2× 416 1.8× 121 0.8× 260 2.0× 32 0.3× 112 3.4k
Haidong Wang China 23 55 0.2× 777 3.3× 70 0.5× 63 0.5× 19 0.2× 80 2.2k
Arpit Bhargava India 23 64 0.2× 680 2.9× 180 1.2× 55 0.4× 8 0.1× 77 1.7k
Yanhong Wang China 22 38 0.1× 352 1.5× 192 1.3× 270 2.1× 17 0.2× 96 1.8k
Vishal Madan United Kingdom 20 92 0.3× 327 1.4× 110 0.7× 509 4.0× 15 0.2× 68 2.1k
Changxi Wang China 23 75 0.2× 372 1.6× 27 0.2× 318 2.5× 32 0.3× 120 1.5k

Countries citing papers authored by Antony P. Martin

Since Specialization
Citations

This map shows the geographic impact of Antony P. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony P. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony P. Martin more than expected).

Fields of papers citing papers by Antony P. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony P. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony P. Martin. The network helps show where Antony P. Martin may publish in the future.

Co-authorship network of co-authors of Antony P. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Antony P. Martin. A scholar is included among the top collaborators of Antony P. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony P. Martin. Antony P. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drahos, Jennifer, Melanie Calvert, Nanxin Li, et al.. (2025). Health-related quality of life and economic impacts in adults with transfusion-dependent β-thalassemia: findings from a prospective longitudinal real-world study. Quality of Life Research. 34(7). 2005–2017.
2.
3.
4.
Houten, Rachel, Antony P. Martin, Claudia Lameirinhas, et al.. (2024). Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis. PharmacoEconomics - Open. 9(1). 27–39. 3 indexed citations
5.
Houten, Rachel, et al.. (2023). Informed consent failures: National Health Service Resolution data. British journal of surgery. 110(8). 993–995. 5 indexed citations
6.
LoGiudice, John, et al.. (2023). Reliability of Long Vein Grafts for Reconstruction of Massive Wounds. Journal of Clinical Medicine. 12(19). 6209–6209. 2 indexed citations
7.
Roche, Nicolás, et al.. (2022). The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review. Respiratory Medicine. 202. 106949–106949. 15 indexed citations
8.
Godman, Brian, et al.. (2021). The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil. Applied Health Economics and Health Policy. 19(4). 557–577. 2 indexed citations
9.
O’Hara, Jamie, Antony P. Martin, Diane J. Nugent, et al.. (2021). Evidence of a disability paradox in patient‐reported outcomes in haemophilia. Haemophilia. 27(2). 245–252. 33 indexed citations
10.
Li, Nanxin, Eileen K. Sawyer, Gregory F. Guzauskas, et al.. (2021). Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model. Journal of Medical Economics. 24(1). 363–372. 8 indexed citations
11.
12.
Martin, Antony P., et al.. (2020). PMU95 A Systematic Literature Review of Preference Studies in Haemophilia. Value in Health. 23. S619–S619. 1 indexed citations
13.
Martin, Antony P., James E. Thomson, L Richardson, et al.. (2020). PRO124 Qualitative Research to Inform the Development of a Discrete Choice Experiment to Examine Preferences of People with Haemophilia for GENE Therapy. Value in Health. 23. S712–S712.
14.
Watson, Paula M., Alan Haycox, Brendan Collins, et al.. (2019). Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions. Social Science & Medicine. 232. 156–167. 8 indexed citations
15.
Pennington, Becky, Brendan Collins, Simon Leigh, et al.. (2018). The cost-effectiveness of seven behavioural interventions to prevent drug misuse in vulnerable populations. International Journal of Drug Policy. 57. 42–50. 3 indexed citations
16.
Opanga, Sylvia, et al.. (2018). Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. Journal of Medical Economics. 21(9). 878–887. 34 indexed citations
17.
Jakupi, Arianit, et al.. (2018). Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications. PharmacoEconomics - Open. 2(4). 423–432. 7 indexed citations
18.
Martin, Antony P., William M. Palmer, Christopher W. Brown, et al.. (2016). A developing Setaria viridis internode: an experimental system for the study of biomass generation in a C4 model species. Biotechnology for Biofuels. 9(1). 44 indexed citations
19.
Rao, Christopher, Arthur Sun Myint, Thanos Athanasiou, et al.. (2016). Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective. Diseases of the Colon & Rectum. 60(1). 30–42. 26 indexed citations
20.
Martin, Antony P., Sarah Richards, Alan Haycox, et al.. (2015). Plerixafor is cost‐effective compared to conventional chemotherapy for first‐line haematopoietic stem cell mobilization: Data from the PHANTASTIC trial. Journal of Clinical Apheresis. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharmistha Ghosh Breakdown of academic impact, for papers by Nengming Lin Breakdown of academic impact, for papers by Amy J. Clippinger Breakdown of academic impact, for papers by Hyun‐Jung Choi Breakdown of academic impact, for papers by Robert Dawe Breakdown of academic impact, for papers by Haidong Wang Breakdown of academic impact, for papers by Arpit Bhargava Breakdown of academic impact, for papers by Yanhong Wang Breakdown of academic impact, for papers by Vishal Madan Breakdown of academic impact, for papers by Changxi Wang
Rankless by CCL
2026